Opes Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,313
Closed -$766K 44
2018
Q2
$766K Buy
6,313
+3,964
+169% +$495K 0.56% 28
2018
Q1
$301K Sell
2,349
-935
-28% -$126K 0.24% 32
2017
Q4
$459K Buy
+3,284
New +$457K 0.33% 30
2017
Q3
Sell
-7,010
Closed -$917K 45
2017
Q2
$917K Buy
7,010
+48
+0.7% +$6.12K 0.57% 29
2017
Q1
$867K Buy
6,962
+4,003
+135% +$478K 0.61% 26
2016
Q4
$341K Buy
+2,959
New +$342K 0.35% 33

Other funds holding JNJ

Opes Advisors's JNJ Position: Q3 2018 in Review

Opes Advisors sold out of Johnson & Johnson (JNJ) in Q3 2018, closing a stake of 6,313 shares — an estimated $766K sold.

Opes Advisors first reported a position in JNJ in Q4 2016 and held it in 6 quarters. The position peaked at $917K in Q2 2017. 2,584 funds tracked by Wall St. Rank hold JNJ as of Q3 2018.

  • Opes Advisors reported no remaining Johnson & Johnson position as of Q3 2018 after selling out during the quarter.
  • Opes Advisors sold 6,313 Johnson & Johnson shares in Q3 2018, an estimated $766K.
  • Opes Advisors first reported a position in Johnson & Johnson in Q4 2016 and held it in 6 quarters.
  • Opes Advisors's Johnson & Johnson position peaked at $917K in Q2 2017.
  • 2,584 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2018.

Based on Opes Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.